1. Home
  2. HXL vs PCVX Comparison

HXL vs PCVX Comparison

Compare HXL & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hexcel Corporation

HXL

Hexcel Corporation

HOLD

Current Price

$79.25

Market Cap

6.6B

Sector

Industrials

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$54.00

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXL
PCVX
Founded
1946
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HXL
PCVX
Price
$79.25
$54.00
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$81.73
$98.33
AVG Volume (30 Days)
1.2M
1.0M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
0.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,893,900,000.00
N/A
Revenue This Year
$10.20
N/A
Revenue Next Year
$12.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.28
$28.09
52 Week High
$95.22
$76.61

Technical Indicators

Market Signals
Indicator
HXL
PCVX
Relative Strength Index (RSI) 30.30 40.80
Support Level $72.85 $42.30
Resistance Level $84.64 $57.50
Average True Range (ATR) 2.73 3.07
MACD -1.62 -0.93
Stochastic Oscillator 14.09 5.10

Price Performance

Historical Comparison
HXL
PCVX

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: